MorphoSys Rises on $818 Million Drug Alliance: Frankfurt Mover

MorphoSys AG rose to a 12-year high after announcing an alliance for an experimental cancer treatment with Celgene Corp. worth as much as 628 million euros ($818 million) plus royalties on sales.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.